Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Ketosis × eribulin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 52 Neoplasms 14 Sarcoma 10 Neoplasm Metastasis 8 Triple Negative Breast Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Unspecified Adult Solid Tumor, Protocol Specific 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Liposarcoma 2 Leiomyosarcoma 2 Carcinoma 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumors 1 Salivary Gland Neoplasms 1 Relapsed Solid Tumors 1 Peripheral Nervous System Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neurotoxicity Syndromes 1 Neoplastic Cells, Circulating 1 Neoplasm, Residual 1 Lymphoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02061085 2025-06-08

MERIBEL

MedSIR

Phase 2 Completed

53 enrolled 11 charts

Breast Neoplasms, Ketosis, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡